Incidence and risk factors of hypertension therapy in Australian cancer patients treated with vascular signalling pathway inhibitors.
Discov Oncol
; 13(1): 6, 2022 Jan 20.
Article
in En
| MEDLINE
| ID: mdl-35201530
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Etiology_studies
/
Incidence_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Discov Oncol
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: